These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10560800)

  • 41. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.
    Vaara S; Pettila V; Kaukonen KM
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):147-57. PubMed ID: 22092254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ertapenem clearance during modeled continuous renal replacement therapy.
    Stevenson JM; Patel JH; Churchwell MD; Vilay AM; Depestel DD; Sörgel F; Kinzig M; Jakob V; Mueller BA
    Int J Artif Organs; 2008 Dec; 31(12):1027-34. PubMed ID: 19115194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.
    Veltri MA; Neu AM; Fivush BA; Parekh RS; Furth SL
    Paediatr Drugs; 2004; 6(1):45-65. PubMed ID: 14969569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Continuous renal replacement therapy].
    Knotek M; Prkacin I; Skegro D; Sabljar-Matovinović M
    Lijec Vjesn; 2001; 123(9-10):255-8. PubMed ID: 11845582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous renal replacement therapy for critically ill patients: an update.
    van Bommel EF; Leunissen KM; Weimar W
    J Intensive Care Med; 1994; 9(6):265-80. PubMed ID: 10155186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey.
    RENAL Study Investigators
    Crit Care Resusc; 2008 Sep; 10(3):225-30. PubMed ID: 18798721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of continuous renal replacement therapy on drug therapy.
    Susla GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
    Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
    Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. We use Continuous Renal Replacement Therapy for Overdoses and Intoxications.
    Cabrera VJ; Shirali AC
    Semin Dial; 2016 Jul; 29(4):275-7. PubMed ID: 27126739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Extrarenal elimination procedures in acute kidney failure].
    Sold M
    Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intermittent versus continuous renal replacement therapy: a matter of controversy.
    Davies HT; Leslie GD
    Intensive Crit Care Nurs; 2008 Oct; 24(5):269-85. PubMed ID: 18394900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysis.
    Boulieu R; Bastien O; Bleyzac N
    Ther Drug Monit; 1993 Apr; 15(2):105-7. PubMed ID: 8389067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Elimination of drugs by hemofiltration. Principles and literature data].
    Hilt H; Keller F
    Anasth Intensivther Notfallmed; 1987 Dec; 22(6):278-82. PubMed ID: 3326424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible removal of topiramate by continuous renal replacement therapy.
    Browning L; Parker D; Liu-DeRyke X; Shah A; Coplin WM; Rhoney DH
    J Neurol Sci; 2010 Jan; 288(1-2):186-9. PubMed ID: 19896679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
    Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
    J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin?
    Jamal JA; Udy AA; Wallis SC; Ranganathan D; McWhinney BC; Ungerer JP; Lipman J; Roberts JA
    Int J Artif Organs; 2015 Aug; 38(8):419-24. PubMed ID: 26349527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Removal of acyclovir during continuous veno-venous hemodialysis and hemodiafiltration with high-efficiency membranes.
    Khajehdehi P; Jamal JA; Bastani B
    Clin Nephrol; 2000 Oct; 54(4):351-5. PubMed ID: 11076113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. To increase or decrease dosage of antimicrobials in septic patients during continuous renal replacement therapy: the eternal doubt.
    Wong WT; Choi G; Gomersall CD; Lipman J
    Curr Opin Pharmacol; 2015 Oct; 24():68-78. PubMed ID: 26667969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous Renal Replacement Therapy: Reviewing Current Best Practice to Provide High-Quality Extracorporeal Therapy to Critically Ill Patients.
    Connor MJ; Karakala N
    Adv Chronic Kidney Dis; 2017 Jul; 24(4):213-218. PubMed ID: 28778360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iohexol transmembrane clearance during modeled continuous renal replacement therapy.
    Yardman-Frank JM; Mercier RC; Wong CS; Vilay AM
    Blood Purif; 2015; 39(1-3):188-192. PubMed ID: 25765443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.